MLL fusion partners AF4 and AF9 interact at subnuclear foci

F Erfurth, CS Hemenway, AC De Erkenez, PH Domer - Leukemia, 2004 - nature.com
F Erfurth, CS Hemenway, AC De Erkenez, PH Domer
Leukemia, 2004nature.com
The MLL gene is involved in translocations associated with both acute lymphoblastic and
acute myelogenous leukemia. These translocations fuse MLL with one of over 30 partner
genes. Collectively, the MLL partner genes do not share a common structural motif or
biochemical function. We have identified a protein interaction between the two most
common MLL fusion partners AF4 and AF9. This interaction is restricted to discrete nuclear
foci we have named 'AF4 bodies'. The AF4 body is non-nucleolar and is not coincident with …
Abstract
The MLL gene is involved in translocations associated with both acute lymphoblastic and acute myelogenous leukemia. These translocations fuse MLL with one of over 30 partner genes. Collectively, the MLL partner genes do not share a common structural motif or biochemical function. We have identified a protein interaction between the two most common MLL fusion partners AF4 and AF9. This interaction is restricted to discrete nuclear foci we have named ‘AF4 bodies’. The AF4 body is non-nucleolar and is not coincident with any known nuclear structures we have examined. The AF4–AF9 interaction is maintained by the MLL–AF4 fusion protein, and expression of the MLL–AF4 fusion can alter the subnuclear localization of AF9. In view of other research indicating that other MLL fusion partners also interact with one another, these results suggest that MLL fusion partners may participate in a web of protein interactions with a common functional goal. The disruption of this web of interactions by fusion with MLL may be important to leukemogenesis.
nature.com